Aurobindo Pharma
AUROPHARMA.NS
#2189
Rank
HK$63.60 B
Marketcap
HK$103.94
Share price
1.23%
Change (1 day)
-19.07%
Change (1 year)

Aurobindo Pharma (AUROPHARMA.NS) - Total liabilities

Total liabilities on the balance sheet as of March 2025 : HK$15.74 Billion

According to Aurobindo Pharma 's latest financial reports the company's total liabilities are HK$15.74 Billion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Aurobindo Pharma - Total liabilities on balance sheet (from 2012 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-03-31HK$14.28 B14.69%
2023-03-31HK$12.45 B29.14%
2022-03-31HK$9.64 B-23.83%
2021-03-31HK$12.66 B1.68%
2020-03-31HK$12.45 B-12.3%
2019-03-31HK$14.20 B25.08%
2018-03-31HK$11.35 B37.84%
2017-03-31HK$8.23 B-22.7%
2016-03-31HK$10.65 B15.27%
2015-03-31HK$9.24 B25.14%
2014-03-31HK$7.38 B10.94%
2013-03-31HK$6.65 B12.17%
2012-03-31HK$5.93 B-0.75%
2011-03-31HK$5.98 B16.14%
2010-03-31HK$5.15 B12.65%
2009-03-31HK$4.57 B-6.08%
2008-03-31HK$4.86 B2.8%
2007-03-31HK$4.73 B45.21%
2006-03-31HK$3.26 B28.55%
2005-03-31HK$2.53 B23.87%
2004-03-31HK$2.04 B